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Use of Brain Electrical Activity for the Identification
of Hematomas in Mild Traumatic Brain Injury
Daniel F. Hanley,1 Robert Chabot,2 W. Andrew Mould,1 Timothy Morgan,3 Rosanne Naunheim,4
Kevin N. Sheth,5 William Chiang,6 and Leslie S. Prichep 2

Abstract

This study investigates the potential clinical utility in the emergency department (ED) of an index of brain electrical
activity to identify intracranial hematomas. The relationship between this index and depth, size, and type of hematoma was
explored. Ten minutes of brain electrical activity was recorded from a limited montage in 38 adult patients with traumatic
hematomas (CT scan positive) and 38 mild head injured controls (CT scan negative) in the ED. The volume of blood and
distance from recording electrodes were measured by blinded independent experts. Brain electrical activity data were
submitted to a classification algorithm independently developed traumatic brain injury (TBI) index to identify the
probability of a CT + traumatic event. There was no significant relationship between the TBI-Index and type of hematoma,
or distance of the bleed from recording sites. A significant correlation was found between TBI-Index and blood volume.
The sensitivity to hematomas was 100%, positive predictive value was 74.5%, and positive likelihood ratio was 2.92. The
TBI-Index, derived from brain electrical activity, demonstrates high accuracy for identification of traumatic hematomas.
Further, this was not influenced by distance of the bleed from the recording electrodes, blood volume, or type of
hematoma. Distance and volume limitations noted with other methods, (such as that based on near-infrared spectroscopy)
were not found, thus suggesting the TBI-Index to be a potentially important adjunct to acute assessment of head injury.
Because of the life-threatening risk of undetected hematomas (false negatives), specificity was permitted to be lower, 66%,
in exchange for extremely high sensitivity.
Key words: hematoma; mild traumatic brain injury; neuroimaging; quantitative EEG

Introduction

P

atients presenting to the emergency department (ED) with
mild traumatic brain injury (mTBI) resulting in intracranial
hematoma must have a rapid diagnosis to prevent significant morbidity and mortality that can occur in the presence of rapidly expanding intracranial hematomas. The current ‘‘gold standard’’ for
initial assessment and triage is non-contrast computed tomography
(CT) scan, performed as soon as possible after injury. The use of CT
is not always possible. Limited access to CT, situations necessitating
rapid triage, concurrent severe multisystem injury, patient tracking to
determine the need for repeated CTs, or even on-scene scans (such as
sporting events or military settings) are all areas where a need exists
to rapidly identify intracranial bleeds.

Prichep and colleagues1 described the development of the TBIIndex, which was based on brain electrical activity recorded from a
limited forehead montage using a handheld device. This index
demonstrated high sensitivity and specificity in the identification of
mTBI. Using this index on ED patients with mTBI with CT findings, it was found that CT positive patients (CT + ) could be discriminated from normal ED controls and from CT negative patients
with mTBI (CT-), with high sensitivity, specificity, and negative
predictive validity (NPV, percentage of CT- patients correctly
identified as having a negative diagnosis).2,3 Comparing the accuracy of detection of CT + injuries using the TBI-Index and the New
Orleans Criteria (NOC, guidelines for referral for CT in the ED),
O’Neil and colleagues3 reported that the specificity of the TBIIndex was more than double that of the NOC in the same patients,
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thus potentially reducing the need to refer for CT scans in those who
were, in fact, found to be CT-.
A number of recent publications have evaluated the use of nearinfrared spectroscopy (NIS) to assess the presence of a cerebral
hematoma in patients who present with mTBI. Such studies reveal
limitations of the efficacy of those assessments including hematoma type, location, and depth.4–7 These limitations greatly restrict
the clinical utility of the reported results.
The present study was designed to investigate the potential
clinical utility of the TBI-Index of brain function in the ED to
identify the presence of various types of intracranial hematomas. In
addition, the relationships between the TBI-Index and the depth
and size of intracranial hematomas were explored.
Methods
Patient population
The study population consisted of a retrospective sample of 274
ED patients who presented with head injury and received CT scans.
Patients were enrolled in the ED at one of the ten sites of the study
(the majority from Washington University, Barnes Jewish Hospital,
Bellevue Hospital Center, and William Beaumont Royal Oak Hospital), after a closed head injury and meeting the inclusion/exclusion
criteria described below. From this, a convenience sample of 38
patients were found to have an intracranial hematoma based on CT
scans obtained after ED admission. A control group of 38 patients
with mTBI whose subsequent CT findings were negative was matched to the hematoma group for sex and age and was selected from
the same above sample of 274 ED head-injured patients.
All sites received approval from their respective Human Subjects Research Committees. Written informed consent was obtained before testing of all subjects. Assessment of the capacity of
the subject to give informed consent was performed using the
Conley criteria.8 mTBI was defined using the American Congress
of Rehabilitation criteria, meeting one of the following: (1) any
period of loss of consciousness (LOC) < 30 min and Glasgow
Coma Scale (GCS) score of 13–15 after LOC; (2) any loss of
memory for the event immediately before or after the injury, with
post-traumatic amnesia less than 24 h; (3) any alteration in mental
state at the time of the event, such as being dazed, disoriented, or
confused. From this sample 38 patients were confirmed to have
intracranial bleeding based on blinded, adjudicated assessment of
ED CT scans.
Inclusion/exclusion criteria
Male and female patients between the ages of 18 and 86 years of
age who presented to the ED after a closed head injury and met the
above mTBI definition were eligible for inclusion. Patient enrollment
occurred during all periods when the research assistants were available and were not selected by referral from treating physicians. Only
those patients who had a CT scan of the head ordered as part of their
clinical evaluation were included in this mTBI sample. Patients were
excluded if clinical conditions would not allow placement of the
electrodes, or if they were obtunded from intoxication to the point at
which they could not provide informed consent. In addition, patients
with known psychiatric disorders, including chronic drug or alcohol
abuse disorders, chronic seizure history, mental retardation, or who
were currently taking prophylactic CNS active medication for a
chronic psychiatric condition, were not eligible for the study. If the
head injury occurred after a seizure, the patient was not a candidate
for this study.
Electroencephalographic (EEG) recording was made before
discharge home and as early as practically possible in the workup of
the patient that would not hinder the care of the patient, with the
vast majority ( > 85%) tested within 24 h.
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CT scans
All CT-scans were initially reviewed by the radiologists/neuroradiologists at each local site of the study. All scans were performed within 20 h of the EEG data acquisition, with a mean of
8.8 h (80% were £ 12 h, and were in the time frame of the standard
of care practiced at the ED site of acquisition). There was no significant difference in mean times between the CT + or CT- populations (t = - 0.535 p = 0.293) evaluations. All measurements of
intracranial hematomas were calculated by two independent neuroradiologically trained technician readers (AM and TM), blinded
to the EEG results. The results were reviewed for congruence, and
all discrepancies, as well as a random sample of 20%, were adjudicated by a third physician reader (DH).
Each hematoma was classified in terms of the lobe or lobes of the
brain compromised (frontal, parietal, temporal, or occipital), the
hemisphere of the brain region affected (left or right), by hematoma
type (epidural [EPH]; subdural [SDH]; or intracerebral [ICH]), and
whether or not a subarachnoid hemorrhage (SAH) was also present.
Quantitative measurements of the volume of blood within the
hematoma were performed with operator-defined region of interest
segmentation using Osirix9 (Fig. 1). To account for multiple hematomas, a single volume was attributed to each unique bleeding
location. For blood spanning multiple lobes but the result of a single
bleeding event, a single volume was placed under the lobe corresponding to the epicenter of the bleed (i.e., a left hemispheric SDH
concentrated in the parietal lobe was measured across all lobes with
one volume marked under P SDH). It is important to note that SAHs
were not assigned a volume.
A quantitative measure of the distance of the bleeding event
from the location of the EEG electrodes (midpoint between FP1 and
FP2) was performed. Two linear measurements (mm) were performed for each unique bleeding event. The first measurement
corresponded to the shortest distance from the bleeding location to
the skull surface location of the BrainScope sensor, FP1 or FP2,
depending on the cerebral hemisphere containing the hematoma.
The second measurement corresponded to the distance from the
same sensor used in the first linear measurement to the epicenter of
the bleed. In some cases, the shortest distance to a bleed needed
measurement to one lobe while the epicenter was located in a
different lobe. SAHs were not measured for linear distances.
Electrophysiological evaluation
All subjects underwent 10 minutes of eyes closed resting EEG
recording acquired on a handheld device. The EEG recordings were
made from frontal electrode sites of the international 10/20 system
using self-adhesive electrodes pasted on the forehead and referenced to linked ears. The frontal electrode sites included FP1, FP2,
AFz (located just anterior to Fz on the forehead, below the hairline),
F7, and F8. All electrode impedances were below 10 kO. Amplifiers had a bandpass from 0.5 to 70 Hz (3 dB points). Electrode
placement in all cases was completed in less than 5 minutes. The
EEG data were subjected to artifact rejection to remove any biologic and non-biologic contamination, such as that from eye
movement or muscle movement. Previous experience has demonstrated that sufficient artifact-free data (60–120 sec) can be obtained from this 10-minute recording (85% in less than 5 minutes).
Quantitative analysis of brain electrical activity
The artifact-free EEG data were then submitted for quantitative
analyses off-line to calculate an independently developed quantitative
EEG (QEEG) quadratic discriminant function, which was derived to
maximally separate a normal ED control population (n = 255) from
patients who had a TBI/concussion (TBI; n = 358). This discriminant
function had high sensitivity and specificity for distinguishing patients
with structural brain damage (CT + ) from those with concussions or
those with normal brain function (ED controls).2
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This binary discriminant classification algorithm was constructed using iterative methods and cross-validation (leave-oneout and 10-fold)10 based on features extracted from all patients in
the algorithm development database. The algorithm consists of a
weighted combination of selected linear and nonlinear features of
brain electrical activity, which mathematically describe the profile
of TBI as distinguished from normal brain activity or brain activity
compromised by concussion. The result is expressed as a discriminant score or index (TBI-Index) used to classify the patient as
most probably belonging to the CT + population based on a
threshold determined on the receiver operator curve of the discriminant function. Based on this threshold, this algorithm has been
demonstrated to have a sensitivity of 95% and NPV of 98%.1
This Index was calculated off-line for each subject in the study,
blinded to any information about the clinical status of the patient. It
is important to point out that patient age was taken into account
before calculation of the TBI-Index because all EEG features were
age-regressed before inclusion in discriminant analyses.11
Results
The 38 hematoma patients were age and sex matched (27 males
and 11 females) with 38 ED control patients with mTBI whose CT
scans were negative. The mean age for the hematoma group was
55.1 years (18.19–86.8), and the mean age for the CT- controls was
53.2 years (18.16–79.74). There was no significant difference for
age between the two groups (t = –1.43, p = 0.33). All cases were
scored using the Marshall Score grading the severity of the
CT + finding. Thirty-two cases were Marshall Score 2, 2 were 3, 1
was 4, and 3 were 5. CT- controls had Marshall Scores of 1. With
respect to the American Congress of Rehabilitation criteria for
mTBI, there were no significant differences between CT + and CTsubjects for presence of amnesia (chi-square 1.134, p = 0.2869),
altered mental status (chi-square 1.545, p = 0.2139), or GCS (chisquare 3.504, p = 0.0612), but significantly more of the CT + group
reported brief LOC (chi-square 12.336, p = 0.0004).
Neuroradiological findings

FIG. 1. (A) Distance from Fp1 sensor to leading edge and
middle of lesion was calculated using the formula c2 = a2 + b2
where a = the number of slices above Fp1 multiplyed by the slice
thickness and b = distance from translocated Fp1 location on the
appropriate slice with the lesion. The equation was then solved for
the direct distance from Fp1 to either the leading edge or the
epicenter of the lesion. (B) Representation of the perimeter of a
subdural (red) or intracranial hematoma (pink). The volume was
calculated by multiplying the area of each region of interest by the
slice thickness.

For the 38 hematoma patients the locations of the hematomas are
shown in Table 1 below. Among these there were: 6 epidural hematomas (EDH), one of which was accompanied by a SAH; 14
subdural hematomas (SDH), 9 of which also had a SAH; and 19
intracranial hematomas (ICH), 13 of which also had a SAH, and 6
who also had a SDH. Hematomas in all regions of interest (frontal,
parietal, occipital and temporal) were represented in this sample
and both hemispheres were represented.
Table 2 gives the volume of blood measured both for the largest
volume within a single region and for the total volume across regions. The average amount of measured bleeding was 12.14 mL
(standard deviation [SD] = 16.41), with the largest volume summed
across regions equal to 13.76 mL (SD = 18.48) and the range of
blood detected 0.13–59.51 mL. The smallest blood volumes measured were those confined to a single 2–5 mm CT slice. There were
no significant differences found between the type of hematoma and
the volume of blood, with mean values of 4.5 mL for EDH, 18.3 mL
for SDH, and 12.9 mL for ICH (sum: F = 1.2, p = 0.3, single largest
region: F = 1.6, p = 0.2).
Also shown in Table 2 is the distance from the frontal electrode
sites where the brain electrical activity was measured to the closest
presence of blood and also to the epicenter of that bleed. The mean
distance from the recording electrodes to the closest blood measured was 55.16 mm (SD = 32.37) and to the epicenter of the bleed
was 78.45 mm (SD = 40.35), with a range of 4.88–160.51 mm.
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Table 1. Age, Sex, Location, and Type
of Hematoma by Region and Hemisphere

Table 1. (Continued)
Region/type

Region/type
Subject Age Sex
1

Frontal

75.4 M

2

25.1 M

3
4

47.0 M
60.6 M

5

71.3 M

6

48.3 M

7

48.3 M

8
9

33.2 M
53.8 M

10

34.0 M

11
12

24.5 F
67.0 M

13
14

23.5 M
73.9 M

15
16

64.1 F
66.7 M

17
18
19
20

27.0
77.3
61.5
84.8

21
22

76.1 F
72.6 F

23
24
25
26

86.8
21.9
58.2
84.8

27
28

30.0 M
59.4 F

29
30
31

61.8 M
69.4 F
59.6 F

32

49.3 F

33

39.8 M

34

18.2 M

35

46.3 M

F
F
M
M

M
M
F
M

Occipital Temporal

R-SDHa
R-SAH
R-ICH
R-SAH

R-SDH
R-SAH

L-SAH

R-SDHa

R-SAH

R-SDHa
R-EDH

R-SDHa

R-SAH
R-SDH
R-SAH

R-SDH

L-SDH*

L-SDH

a

L-EDHa
L-SDH

L-SAH
R-ICH*
R-SDH*
L-SDHa
L-SAH
L-EDH
R-SAH
R-ICH*

L-SAH
L-ICH
R-SAH
R-SAH
R-SDH
R-SAH
R-EDHa
R-SDH
R-SAH
R-ICHa

R-SDHa

R-EDH

L-EDH
L-SDH*

75.2 M
42.2 M

38

75.4 M

Frontal
L-EDH*
L-SDHa
L-ICH
L-SDH
L-SAH

Parietal

Occipital Temporal

R-SAH
L-SDHa

L-SDH

a

Correponds to the largest volume of blood.
R, right; SDH, subdural hematoma; SAH, subarachnoid hemorrhage;
ICH, intracerebral hematoma; L, left; EDH, epidural hematoma.

There was a significant difference found between type of hematoma
and distance to the epicenter of the bleed with 86.6 mm for EDH,
94.8 mm for SDH, and 61.2 mm for ICH (F = 3.3, p = 0.04).
TBI-Index

L-SDHa
L-SAH
L-ICH
R-SDH
R-SDH*
R-SDH
R-SAH
R-ICH
L-SDH
L-SDHa
L-SAH
L-ICH

36
37

a

L-SDH
L-SAH
L-ICHa
L-SAH
L-ICHa

LR-SDHa
LR-SAH
L-SDH
R-ICH*
L-SDH*
L-ICHa

R-SAH

R-SDH
R-ICH
R-SDH
R-SAH

L-ICH*
L-SDH
L-SAH

LR-SAH
L-ICH*
R-ICHa
R-SDH
R-SAH

Subject Age Sex

Parietal

L-SDH
L-SAH
L-EDHa

L-SDHa
L-SAH

L-SDH
R-ICHa
L-EDHa
R-ICH

LR-SAH
R-SDH
L-SDH

R-SDH
L-SDH

L-SAH
L-ICH

L-SAH
L-ICHa

R-SDHa
R-ICH

L-SDH*
(continued)

The TBI-Index is based on a binary discriminant function with a
threshold above which a CT + finding is predicted (see details of the
Index elsewhere1). Table 3 shows the contingency table for the
accuracy of the TBI-Index for discriminating the hematoma patients from the mTBI CT- patients.
Based on the application of the TBI-Index to the hematoma and
mTBI CT- control cases in this study, sensitivity to hematomas was
100%, specificity was 66%, positive predictive value (PPV) was
74.5%, and positive likelihood ratio (PLR) was 2.92. With sensitivity
of 100%, NPV was 100% and negative likelihood ratio (NLR) was 0.
Although the TBI-Index is a binary classifier and, in this sample,
all hematoma cases were correctly identified as being CT + , it is of
interest to look at the correlation with the individually obtained
discriminant scores and the volume and distance measures made. A
significant correlation between the TBI-Index and the volume of
blood present was found for the largest single region (r = .36;
p = 0.028) and for the sum or total volume across regions (r = 0.38,
p = 0.019). There were no significant differences found between the
TBI-Index and the shortest distance to the bleed (r = - 0.13,
p = 0.432) or to the epicenter of the bleed (r = .03; p = 0.854). The
TBI-Index did not vary as a function of hematoma type with the
average discriminant score for SDH = 84.2 (SD = 21.4), ICH = 79.9
(SD = 24.9), and EDH = 62.6 (SD = 35.7). The mean discriminant
score for the mTBI CT- control group was 16.7.
Of most importance is the finding that the TBI-Index was equally
sensitive for indicating abnormal function for EPH, SDH, and ICH,
was not influenced by the distance of the hematoma from the recording electrodes, and was not influenced by the presence or absence of a co-occurring SAH.
Discussion
The results of the present study continue to support the hypothesis that the TBI-Index of brain function/dysfunction can be
used to correctly identify in the ED mTBI patients with intracranial
hematoma seen on CT scan. While this tool is not a substitute for a
CT scan, the data suggest the clinical utility of the tool as an adjunct
to clinical practice currently used for triage of patients with mTBI
or in those situations where CT scans are not readily available.
Importantly, sensitivity to mass lesions in the clinically critical
epidural, subdural, and cerebral hemisphere compartments is
demonstrated.
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Table 2. Blood Volume by Largest within a Single Region
and Summed Across all Regions, and Distance from the
Frontal Electrodes Used in Recording, Both the Shortest
Distance to the Edge of Bleed and the Distance
to the Epicenter, Are Shown for Each Subject
Volume (mL)
Subject
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
Mean
SD

Distance (mm)

Largesta

Sum

Shortest

Epicenter

31.02
2.23
2.86
8.34
9.23
1.88
6.07
4.52
1.41
0.4
3.07
19.89
4.95
40.31
0.15
0.13
12.93
3.34
0.41
59.51
48.54
7.39
4.83
2.56
37.08
4.19
0.73
9.34
0.51
9.54
40.51
42.04
0.25
0.62
2.98
0.54
2.92
34.12
12.14
16.41

37.13
2.23
2.86
19.05
9.23
3.59
7.3
4.52
2.07
0.4
5.59
19.89
4.95
40.31
0.15
0.17
12.93
3.34
0.41
59.99
48.54
8.1
4.83
2.56
37.08
4.19
0.73
10.83
0.51
9.54
40.51
63.73
0.25
0.76
2.98
0.54
3.44
47.65
13.76
18.48

84.32
50.32
29.89
17.28
74.33
26.25
19.71
24.93
62.48
25.84
64.75
26.42
53.85
54.97
85.72
64.13
72.42
85.66
65.12
59.49
22
15.88
70.17
62.25
21.9
160.51
101.14
47.03
109.26
31.88
18.06
4.88
42.84
88.48
68.13
63.84
17.82
26.25
53.16
32.37

89.52
57.05
49.48
21.41
99.52
32.29
20.18
32.4
71.8
30.66
74.96
149.25
67.23
174.62
90.41
65.5
98.84
103.8
84.9
63.66
132.36
16.41
95
105.83
67.11
182.03
120.05
67.93
119.8
68.74
84.73
38.11
45.14
105.48
87.28
79.97
23.01
64.76
78.45
40.35

a
Column showing largest volume corresponds to the region indicated by
‘‘a’’ in Table 1, for the location of the largest volume.
SD, standard deviation.

Although not quantified, the algorithm also appears sensitive to
SAH. Because emergency treatments exist for each of these locations, the potential to add clinically directive value to emergent care
by sensitive screening for all types of brain bleeding and promoting
rapid definitive diagnosis with CT appears promising.
The variables that contributed most to the classification algorithm included monopolar and bipolar scale-free features for the
total spectrum that evaluates the global complexity of the brain
electrical activity, especially in the theta frequency band; monopolar and bipolar power shifts, especially in theta; disturbances in
coherence relationships between regions, especially in high frequencies (alpha2, gamma); shifts in phase synchrony, especially in
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Table 3. Contingency Table for the Accuracy
of Traumatic Brain injury-Index Applied
to the Hematoma Data
CT results
TBI-Index
Positive
Negative

CT +

CT -

38
0

13
25

CT, computed tomography.

high frequencies, and fractal features. The fact that all subjects in
this study were classified as abnormal on this discriminant suggests
that these features are useful in describing the changes in brain
electrical activity seen in this subpopulation.
Further, the TBI-Index score varied as a function of the size of the
bleed with larger scores for larger volumes. Thus, this technique may
also prove useful for following patients with documented intracranial
hematoma for expansion of lesions when expectant observation is
being performed in lieu of surgery or for patients with EPH during a
lucid interval. It may prove capable of defining interval change in
bleeding mass and therefore be useful in determining if repeated CT
is advised. The fact that the EEG analyzed within this study was
collected from an easily applied frontal montage of recording electrodes using a handheld device increases its clinical utility for environments that would not be suitable for conventional EEG
collection.
The Food and Drug Administration (FDA) recently issued approval of a handheld near-infrared brain hematoma detection device. In the application for this device, clinical data were reported
showing a sensitivity of 74.6% for the detection of ICH greater than
3.5 mL and less than 2.5 cm from the brain surface. Specificity was
81.6% for no hematoma or hematoma less than 3.5 mL and greater
than 2.5 cm from the brain surface. These limitations for size and
location were stipulated in the FDA cleared Indications for
Use,12,13 potentially reduce NIS clinical utility. In contrast, correct
identification of mTBI hematoma using the TBI-Index was independent of lobar location as defined by measuring the distance from
the forehead recording electrodes to the site of the bleed, with
bleeds in the frontal, parietal, occipital, and temporal regions all
being correctly identified. More specifically, the majority of the
hematomas were located farther from the brain surface, with
smaller volumes than the limitations that apply to the Infrascan,
with 29 of the 38 (based on shortest distance) and 34 of the 38
(based on distance to epicenter) located greater than 2.5 cm from
the recording electrodes and 18 of the 38 (based on largest volume)
and 16 of the 38 (based on total volume) with volumes less than
3.5 mL.
Strong evidence was presented that the TBI-Index was not
influenced by the distance of the bleed from the EEG recording
electrodes. It was also sensitive to a wide and clinically important
range of bleed volumes. Thus, this radiographic evaluation of bleed
type and location is consistent with the hypothesis that the TBIIndex algorithm can identify all types of intracranial bleeding.
Although this data set is small, it did not demonstrate the distance
related limitation of detection sensitivity noted above with methods
based on NIS.
There are several limitations to the above study. The number of
hematoma patients was small, especially when one attempts to look
at results across regions of the brain impacted by the hematoma.
The number of EPH in the present study was limited in respect to
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those with SDH and ICH. Many subjects had multiple locations for
their hematomas. The lack of a ‘‘gold standard’’ for the CT- group
is another weakness. It is noted that the stratification of risk was
heavily on the side of correct detection of hematomas, resulting in a
lower than otherwise specificity in CT- brain-injured patients.
While the CT + and CT- controls were well matched (age, sex, and
symptoms of mTBI), there was a higher incidence of reported brief
LOC at the time of the injury in the CT + group, suggesting that the
inclusion of a CT- control group matched for LOC might be important to explore.
The high mean age of our patient samples (55 years) appeared to
be a function of our clinical criteria that selected a moderately
severe injury with a range of brain bleedings in still conscious
(GCS > 8) subjects. Because this sample was taken from a set of 10
EDs, it was believed to be representative of ED populations, and
together with the use of age regression of all EEG features, believed
to be generalizable across the adult age range. Another concern
about generalizability relates to exclusion criteria. These criteria,
however, were necessarily applied to minimize problems of informed consent. While obtunded subjects were not candidates for
this study, the presence of drugs and/or alcohol per se was not a
criterion for exclusion, and such subjects were not found to perform
differently on the algorithm. Future studies may more fully examine the effects of higher levels of alcohol and drugs and the
presence of known substance dependence disorders on the performance of the TBI-Index.
Conclusions
EEG based measures of brain function/dysfunction may provide
information suggesting the presence of an ICH in patients with
mTBI presenting to the ED. While such a tool is not meant to
replace a CT scan, it offers a possible alternative to be used in triage
situations or in situations where no CT scan is available. For example, it could be implemented while transporting a patient from an
accident scene to a hospital where more extensive testing would be
available. The present results suggest that this technology is sensitive to the presence of EDH, SDH, and ICH and is not restricted to
large hematomas only and not restricted by the distance of the
hematoma from EEG recording electrodes. Future studies should
examine: a greater number of CT + subjects, the effects of chronic
drug and alcohol disorders on sensitivity and specificity levels, as
well as to study serial TBI-Index recordings after hematoma to
document future increased bleeding events.
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